Evaluation of reactivation of HSV1, HHV6, CMV and EBV in a population of patients undergoing allogeneic bone marrow transplantation

Caterina Matinato; Giovanna Lunghi; Anna Orlandi; Silvia Melotti; Antonella Zoccoli; Damiano Picicco; Erminio Torresani

doi:10.4081/mm.2011.2367

Evaluation of reactivation of HSV1, HHV6, CMV and EBV in a population of patients undergoing allogeneic bone marrow transplantation

https://doi.org/10.4081/mm.2011.2367

PDF

Vol. 26 No. 2 (2011)

Submitted: 13 February 2014
Accepted: 13 February 2014

Published: 30 June 2011

Bone marrow transplantation, Herpes virus reactivation, aGVDH

Abstract Views: 1104

PDF: 1388

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Herpes viruses are recognized as important pathogens as a result of viral reactivation in immunocompromised hosts, especially in patients undergoing bone marrow transplantation. Objectives of this study were the assessment of the reactivation of herpes virus HSV1, HHV6, CMV and EBV and the correlation between viral reactivation and progression of transplantation in a population of patients undergoing allogeneic bone marrow transplantation at Fondazione IRCCS Ospedale Maggiore Ca’ Granda Policlinico, Milan. Viral DNA was detected and quantified by Real Time PCR in a population of 35 patients undergoing allogeneic bone marrow transplantation. The viral reactivation was observed in 7 patients for HSV1 (20%), 6 patients for HHV6 (17.1%), 11 patients for CMV (31.4%) and 4 patients for EBV (11.4%). Difference in the incidence of aGVDH between patients with viral reactivation versus those for which there was no reactivation was statistically significant. These data confirm the importance of monitoring viral load for the management of antiviral therapy in order to prevent CMV disease and complications related to herpes viruses reactivation.

Matinato, C., Lunghi, G., Orlandi, A., Melotti, S., Zoccoli, A., Picicco, D., & Torresani, E. (2011). Evaluation of reactivation of HSV1, HHV6, CMV and EBV in a population of patients undergoing allogeneic bone marrow transplantation. Microbiologia Medica, 26(2). https://doi.org/10.4081/mm.2011.2367